320 related articles for article (PubMed ID: 22705041)
1. Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics.
Revel FG; Moreau JL; Gainetdinov RR; Ferragud A; Velázquez-Sánchez C; Sotnikova TD; Morairty SR; Harmeier A; Groebke Zbinden K; Norcross RD; Bradaia A; Kilduff TS; Biemans B; Pouzet B; Caron MG; Canales JJ; Wallace TL; Wettstein JG; Hoener MC
Biol Psychiatry; 2012 Dec; 72(11):934-42. PubMed ID: 22705041
[TBL] [Abstract][Full Text] [Related]
2. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
[TBL] [Abstract][Full Text] [Related]
3. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Revel FG; Moreau JL; Gainetdinov RR; Bradaia A; Sotnikova TD; Mory R; Durkin S; Zbinden KG; Norcross R; Meyer CA; Metzler V; Chaboz S; Ozmen L; Trube G; Pouzet B; Bettler B; Caron MG; Wettstein JG; Hoener MC
Proc Natl Acad Sci U S A; 2011 May; 108(20):8485-90. PubMed ID: 21525407
[TBL] [Abstract][Full Text] [Related]
4. Trace amine-associated receptor 1 modulates dopaminergic activity.
Lindemann L; Meyer CA; Jeanneau K; Bradaia A; Ozmen L; Bluethmann H; Bettler B; Wettstein JG; Borroni E; Moreau JL; Hoener MC
J Pharmacol Exp Ther; 2008 Mar; 324(3):948-56. PubMed ID: 18083911
[TBL] [Abstract][Full Text] [Related]
5. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.
Black SW; Schwartz MD; Chen TM; Hoener MC; Kilduff TS
Biol Psychiatry; 2017 Nov; 82(9):623-633. PubMed ID: 27919403
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques.
Goonawardena AV; Morairty SR; Dell R; Orellana GA; Hoener MC; Wallace TL; Kilduff TS
Neuropsychopharmacology; 2019 Jul; 44(8):1485-1493. PubMed ID: 30954024
[TBL] [Abstract][Full Text] [Related]
7. Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition.
Schwartz MD; Black SW; Fisher SP; Palmerston JB; Morairty SR; Hoener MC; Kilduff TS
Neuropsychopharmacology; 2017 May; 42(6):1305-1314. PubMed ID: 27658486
[TBL] [Abstract][Full Text] [Related]
8. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
Pei Y; Mortas P; Hoener MC; Canales JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
[TBL] [Abstract][Full Text] [Related]
9. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
10. Activation of trace amine-associated receptor 1 attenuates schedule-induced polydipsia in rats.
Sukhanov I; Dorotenko A; Dolgorukova A; Hoener MC; Gainetdinov RR; Bespalov AY
Neuropharmacology; 2019 Jan; 144():184-192. PubMed ID: 30366004
[TBL] [Abstract][Full Text] [Related]
11. A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight.
Revel FG; Moreau JL; Pouzet B; Mory R; Bradaia A; Buchy D; Metzler V; Chaboz S; Groebke Zbinden K; Galley G; Norcross RD; Tuerck D; Bruns A; Morairty SR; Kilduff TS; Wallace TL; Risterucci C; Wettstein JG; Hoener MC
Mol Psychiatry; 2013 May; 18(5):543-56. PubMed ID: 22641180
[TBL] [Abstract][Full Text] [Related]
12. Potential of Ligands for Trace Amine-Associated Receptor 1 (TAAR1) in the Management of Substance Use Disorders.
Wu R; Li JX
CNS Drugs; 2021 Dec; 35(12):1239-1248. PubMed ID: 34766253
[TBL] [Abstract][Full Text] [Related]
13. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
[TBL] [Abstract][Full Text] [Related]
14. TAAR1-dependent effects of apomorphine in mice.
Sukhanov I; Espinoza S; Yakovlev DS; Hoener MC; Sotnikova TD; Gainetdinov RR
Int J Neuropsychopharmacol; 2014 Oct; 17(10):1683-93. PubMed ID: 24925023
[TBL] [Abstract][Full Text] [Related]
15. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system.
Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733
[TBL] [Abstract][Full Text] [Related]
16. A partial trace amine-associated receptor 1 agonist exhibits properties consistent with a methamphetamine substitution treatment.
Pei Y; Asif-Malik A; Hoener M; Canales JJ
Addict Biol; 2017 Sep; 22(5):1246-1256. PubMed ID: 27193165
[TBL] [Abstract][Full Text] [Related]
17. Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function.
Di Miceli M; Omoloye A; Gronier B
J Psychopharmacol; 2019 Jan; 33(1):109-121. PubMed ID: 30334678
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
19. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
[TBL] [Abstract][Full Text] [Related]
20. The Action of TAAR1 Agonist RO5263397 on Executive Functions in Rats.
Dorotenko A; Tur M; Dolgorukova A; Bortnikov N; Belozertseva IV; Zvartau EE; Gainetdinov RR; Sukhanov I
Cell Mol Neurobiol; 2020 Mar; 40(2):215-228. PubMed ID: 31734895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
